THIBAULT LANCE E

Chief Financial Officer at Finch Therapeutics Group, Inc. · on record since May 16, 2023
CFO & Treasurer at DECODE GENETICS INC · on record since Mar 7, 2007
See Remarks at PERFORMANCE TECHNOLOGIES INC \DE\ · on record since Feb 10, 2016
Acting Chief Financial Officer at PALVELLA THERAPEUTICS, INC. · on record since Feb 13, 2017
Chief Financial Officer at ZETA ACQUISITION CORP II · on record since Aug 31, 2021
See Remarks at Arcellx, Inc. · on record since Feb 3, 2022

Insider trading activity of THIBAULT LANCE E

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
DECODE GENETICS INC	Feb 21, 2008	AwardD	50,000	0.00	$0	SEC
DECODE GENETICS INC	Mar 7, 2007	AwardD	150,000	0.00	$0	SEC
DECODE GENETICS INC	Nov 19, 2003	AwardD	50,000	0.00 USD	—	SEC
DECODE GENETICS INC	Sep 2, 2003	Award	5,859	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
DECODE GENETICS INC	Feb 21, 2008	AwardD	50,000	0.00	$0	SEC
DECODE GENETICS INC	Mar 7, 2007	AwardD	150,000	0.00	$0	SEC
DECODE GENETICS INC	Nov 19, 2003	AwardD	50,000	0.00 USD	—	SEC
DECODE GENETICS INC	Sep 2, 2003	Award	5,859	0.00 USD	—	SEC